NEWS & EVENTS | www.rikshospitalet.no - HOSPITAL PAGES IN NORWEGIAN

Lymphoma research at the Norwegian Radium Hospital

 
Harald Holte, leader
Harald Holte, leader
The Lymphoma program consists of clinicians, pathologists and radiologists at the Hospital and researchers at the Cancer Institute with dedication for malignant lymphomas. Both an optimal care and treatment plan for our patients, clinical studies as well as translational and molecular/biological lymphoma research are in focus.


Main focus areas of our research:

1. High dose therapy and stem cell research

2. Immunotherapy

3. Lymphoma biology

4. Late effects and quality of life


We have during the last decade had broad international cooperation with i.e. the Nordic Lymphoma Group and other European study groups like the German and British Lymphoma Groups, the European Bone Marrow Transplantation Group (EBMT) and European Organisation for Research and Treatment of Cancer (EORTC). The Norwegian Radium Hospital is one of three European Hospitals which are members of the Lymphoma and Leukemia Molecular Profiling Project, headed by National Cancer Institute, US.
 
 

Latest articles

Lymphompa treatment programme

 

Linch DC, Yung L, Smith P, Maclennan K, Jack A, Hancock B, Cunningham D, Hoskin P, Qian W, Holte H, Boesen AM, Grigg A, Browett P, Trneny M
Final analysis of the UKLG LY02 trial comparing 6-8 cycles of CHOP with 3 cycles of CHOP followed by a BEAM autograft in patients <65 years with poor prognosis histologically aggressive NHL
Br J Haematol (in press)
PubMed 20201949

Tauro S, Cochrane L, Lauritzsen GF, Baker L, Delabie J, Roberts C, Mahendra P, Holte H
Dose-intensified treatment of Burkitt lymphoma and B-cell lymphoma unclassifiable, (with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma) in young adults (<50 years): A comparison of two adapted BFM protocols
Am J Hematol (in press)
PubMed 20201088

Tierens AM, Holte H, Warsame A, Ikonomou IM, Wang J, Chan WC, Delabie J
Low levels of monoclonal small B-cells in the bone marrow of patients with diffuse large B-cell lymphoma of activated B-cell type but not of germinal center B-cell type
Haematologica (in press)
PubMed 20145271



More publications

 
>> Print this page  [4518 visits]